Norlanco Outpatient Center is categorized under Rheumatologists in Elizabethtown, PA and active since 2007.
Norlanco Outpatient Center was established in 2007, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Rheumatologists business, which does work in the B2C market, and is classified as a Rheumatologists, under code number 6214981 by the NAICS.
If you are seeking more information, feel free to contact Regina Scanlin, Manager at the company’s single location by writing to 424 Cloverleaf Road, Elizabethtown, Pennsylvania PA 17022 or by phoning (717) 928-2001. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Norlanco Outpatient Center |
| Contact Person: | Regina Scanlin, Manager |
| Address: | 424 Cloverleaf Road, Elizabethtown, Pennsylvania 17022 |
| Phone Number: | (717) 928-2001 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Rheumatologists |
| SIC Code: | 8011 |
| NAICS Code: | 6214981 |
| Share This Business: |
Norlanco Outpatient Center was started in 2007 to provide professional Rheumatologists under the SIC code 8011 and NAICS code 6214981. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Regina Scanlin, Manager for inquiries that concern Norlanco Outpatient Center by calling the company number (717) 928-2001, as your correspondence is most welcome. Additionally, the physical location of the single location of Norlanco Outpatient Center can be found at the coordinates 40.13277,-76.5632 as well as the street address 424 Cloverleaf Road in Elizabethtown, Pennsylvania 17022.
For its online presence, you may visit Norlanco Outpatient Center’s website at and engage with its social media outlets through on Twitter and on Facebook.